Teva launches generic Symbyax

JERUSALEM — Teva has launched a generic version of an Eli Lilly drug.

The drug maker said it has launched olanzapine and fluoxetine capsules in the 6-mg/25-mg, 12-mg/25-mg, 6-mg/50-mg, and 12-mg/50-mg strengths. The drug is a generic version of Symbyax, an acute treatment of treatment-resistant depression and bipolar I depression in adults.

Symbyax had annual sales of approximately $82 million in the United States, according to on IMS sales data.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.